Send feedback

LARS2 p.Val336=

c.1008C>T · rs142803778 · VCV504761

Likely benign Multiple submitters
Classification
Likely benign
ClinVar
Review
Multiple submitters ★★☆☆
ClinVar · 7 submitters
gnomAD v4.1
Rare
rare (popmax 0.842%, mid)

Computational evidence

Protein change
Missense predictors do not apply to this variant type; conservation carries the signal.
Splicing
SpliceAI—not assessed · no allele here is in the release
Constraint at this position
ConservationphyloP 0.14GERP -1.4, phastCons 0.78
Overall
CADD6.312PHRED · no single calibrated threshold — expert panels disagree

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.842% Middle Eastern · 51/6,054 alleles
Filtering AF 0.658% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.592%
Overall 0.0545% 879/1,614,052 alleles · rare exomes 787/1,461,772 · genomes 92/152,280 · joint denominator
Ancestry group Frequency 1 in
Middle Easterngrpmax 0.842% 119
South Asian 0.202% 495
Admixed American 0.108% 923
Remaining individualsnot grpmax-eligible 0.0864% 1,158
European (non-Finnish) 0.0437% 2,287
African / African-American 0.012% 8,337

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
LARS2
Protein
p.Val336=
Coding
c.1008C>T
MANE Select
NM_015340
dbSNP
rs142803778
Type
single nucleotide variant
Location
chr3:45476617 (GRCh38)
Gene constraint
LOEUF 0.808 · pLI <0.01 (gnomAD)
Structure
AlphaFold pLDDT 90.57
Full LARS2 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/lars2-p-val336 (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown